Gynaecological and reproductive health issues in HIV-positive women;Gynécologiques et de santé génésique des femmes séropositives

West African Journal of Medicine

Volumn 29, Issue 3, 2010, Pages 135-142

  Agboghoroma, Chris Ovoroyeguono ^a  

^a NATIONAL HOSPITAL   (Nigeria)

Author keywords

AIDS; Antiretroviral therapy; Cervical cytology; Contraception; HIV; Infertility; Pelvic infections; Reproductive health

Indexed keywords

ANTIRETROVIRUS AGENT;

CONTRACEPTION; COUNSELING; DISEASE SEVERITY; GYNECOLOGICAL EXAMINATION; HEALTH CARE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFERTILITY; MEDLINE; PELVIC INFLAMMATORY DISEASE; QUALITY OF LIFE; RELAPSE; REPRODUCTIVE HEALTH; REVIEW; SCIENTIFIC LITERATURE; SEXUALLY TRANSMITTED DISEASE; TREATMENT FAILURE; UTERINE CERVIX CYTOLOGY;

ANTI-HIV AGENTS; CONTRACEPTION; FEMALE; GENITAL DISEASES, FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INFERTILITY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPRODUCTION;

EID: 79960886400     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. UNAIDS and WHO. AIDS epidemic update: December 2007; Geneva: UNAIDS. 2007
2. Pallela FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-60.
3. Townsend C, Cortina-Borja M, Peckham C, Lyall H, de Ruiter A, Tookey P. Very low risk of mother-tochild transmission of HIV in women on HAART achieving viral suppression in the UK and Ireland. AIDS 2008; 22: 973-981.
4. Agboghoroma OC. Management of HIV in Pregnancy: A Clinical Review. Tropical Journal of Obstetrics and Gynaecology 2005; 22: 65-73.
5. Mbu ER, Kongnyuy EJ, Mbopi-Keou FX, Tonye RN, Nana PN, Leke RJI. Gynaecological morbidity among HIV positive pregnant women in Cameroon. Reproductive Health 2008; 5:3. Available at: http://www.reproductivehealth-journal.com/content/5/1/3. Assessed on 6th March 2009.
6. Keiser O, de Tejada BM, Wunder D, Chapuis-Taillard C, Zellweger C, Zinkernagel AS et al. Frequency of gynaecologic follow-up and cervical cancer screening in the Swiss HIV cohort study. Journal of Acquired Immune Deficiency Syndromes 2006; 43: 550-555.
7. Brabin L. Clinical management and prevention of sexually transmitted diseases: A review focusing on women. Acta Trop. 2000; 75: 53-70.
8. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice; the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3-17.
9. Sebitloane MH. HIV and Gynaecological Infections. Best Practice & Research Clinical Obstetrics and Gynaecology. 2005; 19: 231-241.
10. Bukusi EA, Cohen CR, Stevens CE, Sinei S, Reilly M, Grieco V, et al. Effects of human immunodeficiency virus 1 infection on microbial origin of pelvic inflammatory disease and on efficacy of ambulatory oral therapy. Am J Obstet Gynecol 1999; 181: 1374-1381.
11. Fakoya A, Lamba H, Mackie N, Nandwani R, Brown A, Bernard EJ et al. British HIV Association, BASHH, FSRH guidelines for the Management of the sexual and reproductive health of people living with HIV infection 2008. HIV Medicine 2008; 9: 681-720.
12. Parkin DM, Bray FI and Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37: 554-566.
13. Danso D, Lyons F and Bradbeer C. Cervical screening and management of cervical intraepithelial neoplasia in HIVpositive women. Int J STD & AIDS 2006; 17: 579-586.
14. Moodley M, Moodley J and Kleinschmidt I. Invasive cancer and human papillomavirus virus (HIV) infections: a South African perspective. Int J Gynaecol Cancer 2001; 11: 194-197.
15. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infections and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269: 729.
16. Centres for Disease Control and Prevention. Rockville, MD: CDC National Prevention Information Network, 2004.
17. Walboomers KM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
18. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. et al. Human papilloma-virus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 1343-9.
19. Minkoff H, Feldman J, Dehovitz J, Landesman S and Burk R. A longitudinal study of human papillomavirus carriage in human immunodeficiency virusinfected and human immunodeficiency virus uninfected women. Am J Obstet Gynecol 1998; 178: 982-6.
20. Six C, Heard I, Bergeron C, Orth G, Poveda JD, Zaqury P, et al. Comparative prevalence, incidence and short term prognosis of cervical squamous intraepithelial lesions amongst HIVpositive and HIV-negative women. AIDS 1998; 12: 1047-56.
21. Vernon SD, Hart CE, Reeves WC, Icenogle JP. The HIV-1 tat protein enhances E2-depended human papillomavirus 16 transcription. Virus Res 1993; 27: 133-45.
22. Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, et al. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst 2004; 96: 1070.
23. Burghardt E, Holzer E. Treatment of carcinoma in situ: Evaluation of 1609 cases. Obstet Gynecol 1980; 55: 539-45.
24. Wright TC Jr., Koulos J, Schnoll F, Swanbeck J, Ellerbrock TV, Chiasson MA, et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol 1994; 55: 253-8.
25. Maiman M, Watts DH, Andersen J, Clax P, Merino M, Kendall MA, et al. Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomised trial. Obstet Gynecol 1999; 94: 954-61.
26. Chirenje ZM. HIV and cancer of the cervix. Best Practices & Research Clinical Obstetrics and Gynaecology 2005; 19: 269-276.
27. Fylkesnes K, Ndhlovu Z, Kasumba K, Mubanga Musonda R and Sichone M. Studying dynamics of the HIV epidemic: population-based data compared with sentinel surveillance in Zambia. AIDS 1998; 12: 1227-1234.
28. Irwin KL, Moorman AC, O'Sullivan MJ, Sperling R, Koestler ME, Soto I, et al. Influence of human immunodeficiency virus infection on pelvic inflamatory disease. Obstet Gynecol 2000; 95: 525-33.
29. Clark R, Mulligan K, Stamenovic E, Chang B, Watts H, Andersen J, et al. Frequency of anovulation and early menopause among women enrolled in selected AIDS clinical trials group studies. J Infect Dis 2001; 184: 1325-7.
30. Dulioust E, Le Du A, Costagliola D, Gulbert J, Kunstmann JM, Heard I, et al. Semen alterations in HIV-1 infected men. Hum Reprod 2002; 17: 2112-18.
31. Coll O, Fiore S, Floridia M, Giaquinto C, Grosch-Worner I, Guiliano M, et al. Pregnancy and HIV infection: a European concensus on management. AIDS 2002; 16: 1-18.
32. Chen JL, Phillips KA, Kanose DE, Collins RL, Miu A. Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect 2001; 33: 144-152.
33. Chama C, Morrupa J and Gashau W. Sex and reproduction among HIVinfected people in Maiduguri, Nigeria. Journal of Obstetrics and Gynaecology 2007; 27: 812-815.
34. The Practice Committee of the American Society for Reproductive Medicine. Guidelines for reducing the risk of viral transmission during fertility treatment. Fertil Steril 2008; 90: S156-162.
35. The ESHRE Ethics and Law Task Force. Taskforce 8 ethics of medically assisted fertility treatment for HIV positive men and women. Hum Reprod 2004; 19: 2454-6.
36. Gilling-Smith C, Nicopoulos JD, Semprini AE, Frodsham LC. HIV and reproductive care-a review of current practice. BJOG 2006; 113: 869-878.
37. Vernazza PL, Hollander L, Semprini AE, Anderson DJ, Duerr A. HIV-discordant couples and parenthood: how are we dealing with the risk of transmission? AIDS 2006; 40: 635-636.
38. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwre-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group: N Engl J Med 2000; 342: 921-929.
39. Barreiro P, Del Romero J, Leal M, Hernando V, Asencio R, De Mendoza C, et al. Natural Pregnancies in HIVserodiscordant couples receiving successful antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 43: 324-326.
40. Luizzi G, Chirianni A, Clementi M, Bagnarelli P, Valenza A, Cataldo PT, et al. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compactments in a cross-sectional and longitudinal study. AIDS 1996; 10: 51-56.
41. Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, et al. Insemination of HIV-negative women with processed semen of HIVpositive partners. Lancet 1992; 340: 1317-1319.
42. Bujan L, Hollander L, Coudert M, Gilling-Smith C, Vucetich A, Guibert J, et al. Safety and efficacy of sperm washing in HIV-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 2007; 21: 1909-1914.
43. Savasi V, Fernazzi E, Lanzani C, Oneta M, Parrilla B, Persico T. Safety of sperm washing and ART outcome in 741 HIV-1 sero-discordant couples. Hum Reprod 2006; 22: 772-777.
44. Sauer MV, Chang PL, Establishing a clinical program for human immunodeficiency virus 1-seropositive men to father seronegative children by means of in vitro fertilization with intracytoplasmic sperm injection. American Journal of Obstetrics and Gynaecology 2002; 186: 627-33.
45. Mencaglia L, Falcone P, Lentini GM, Consigli S, Pisoni M, Lofiego V, Guidetti R, Piomboni P, De leo V. ICSI for treatment of human immunodeficiency virus and hepatitis C virus-serodiscordant couples with infected male partner. Hum Reprod 2005; 20: 2242-2246.
46. Sauer MV, Wang JG, Douglas NC, Nakhuda GS, Vardhana P, Jovanovic V, Guarnaccia MM. Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 2009; 91: 2455-60.
47. World Health Organization. Strategic approaches to the prevention of HIV infection in infants. Report of a WHO meeting, Morges Switzerland, 20-22 March 2002. Geneva, WHO, 2002.
48. United Nations Population Division (UNPD). Department of Economic & Social Affairs. World contraceptive use 2007. New York, United Nations 2008. Available on-line at: www.un.org/esa/population/publications/contraceptive2007. Accessed on March 6th 2009.
49. World Health Organization Department of Reproductive Health and Research (WHO/RHR). Medical eligibility criteria for contraceptive use. Third edition. Geneva, WHO. 2004. Available:http:/www.who.int/reproductive-health/publications. Accessed on March 3rd 2009
50. World Health Organization Department of Reproductive Health and Research (WHO/RHR). Medical eligibility criteria for contraceptive use. 2008 update. Geneva: WHO, 2008. Available: http:/www.who.int/reproductive-health/publications/mec/mec_update2008.pdf. Accessed on March 3rd 2009
51. World Health Organization. Effectiveness of male latex condoms in protecting against pregnancy and sexually transmitted infections. Geneva: World Health Organization. Fact Sheet No. 243, 2000
52. Holmes KK, Levine R, Weaver M, Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82: 454-461.
53. Nakajima ST. Contemporary Guide to Contraception. 2nd edition. Handbooks in Health Care Co. Newton, USA, 2006
54. Fisher M, Benn P, Evans B, Pozniak A, Jones M, MacLean S, Davidson O, Summerside J, Hawkins D. UK Guidelines for the use of post-exposure prophylaxis for HIV following sexual exposure. International Journal of STD & AIDS 2006; 17: 81-92.
55. Cejtin HEJ. Effect of hormonal contraceptive use on plasma HIV-1 RNA levels among HIV-infected women. AIDS 2003; 17: 1702-4.
56. Wang CC, Reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive pill users: a meta-analysis. J Acquir Immune Defic Syndr 1999; 21: 51-58.
57. Lavreys L, Choham V, Overbaugh J, Hassan W, McClelland RS, Kreiss J, et al. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS 2004; 695-697.
58. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. Drug interactions with hormonal contraception. FFPRHC Guidance (April 2005). J Fam Plann Reprod Health Care 2005; 31: 139-151.